Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata

J Virol. 1999 Dec;73(12):9827-31. doi: 10.1128/JVI.73.12.9827-9831.1999.

Abstract

Our previous reports indicated that Epstein-Barr virus (EBV) contributes to the malignant phenotype and resistance to apoptosis in Burkitt's lymphoma (BL) cell line Akata (N. Shimizu, A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada, J. Virol. 68:6069-6073, 1994; J. Komano, M. Sugiura, and K. Takada, J. Virol. 72:9150-9156, 1998). Here we report that the EBV-encoded small RNAs (EBERs) are responsible for these phenotypes. Transfection of the EBER genes into EBV-negative Akata clones restored the capacity for growth in soft agar, tumorigenicity in SCID mice, resistance to apoptotic inducers, and upregulated expression of bcl-2 oncoprotein that were originally retained in parental EBV-positive Akata cells and lost in EBV-negative subclones. This is the first report which provides evidence that virus-encoded RNAs (EBERs) have oncogenic functions in BL cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Burkitt Lymphoma / virology*
  • Cell Division
  • Cell Transformation, Neoplastic*
  • Cell Transformation, Viral*
  • Gene Expression
  • Herpesvirus 4, Human / genetics*
  • Mice
  • Mice, SCID
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • RNA, Viral / physiology*
  • Transfection
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • Epstein-Barr virus encoded RNA 1
  • Epstein-Barr virus encoded RNA 2
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Viral